∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
---|---|---|---|---|
7PQCP-CSA - 7 Programma Quadro_Collaborative Project/Network/Coordination and Support Action |
Coordination, rationalisation and integration of antimalarial drug discovery initiatives
|
|
Closed | 2009 |
MIS - Bandi Ministero Salute |
Convenzione per l'assolvimento dei compiti di natura tecnico-scientifica di cui al Decreto Legislativo 17 marzo 1995, n. 194, ed al D.P.R. n.290/2001, gravanti sullo stao italiano in ottemperanza ai regolamenti (CE) n. 396/2005, n. 1107/2009 e alla direttiva 2009/128/CE, in materia di prodotti fitosanitari
|
|
Closed | 2015 |
CONTR_RIC - Contratti di ricerca finanziata da altri enti di ricerca |
Convenzione per attività di ricerca nell'ambito del progetto "Pregnenolone for the treatment of L-DOPAinduced dyskinesia in Parkinson's disease"
|
|
Closed | 2021 |
7PQCP-CSA - 7 Programma Quadro_Collaborative Project/Network/Coordination and Support Action |
Convenience Food Enriched with Marine based Raw Materials
|
|
Closed | 2014 |
7PQ_MC - 7 Programma Quadro_Marie Curie ITN_IEF_IOF_IIF_IAPP |
Control of metabolic and inflammatory pathways by nuclear receptor
|
|
Closed | 2013 |
FON_NAZ - Bandi Altre Fondazioni |
Contribution of lipids and their oxidized metabolites on Arrhythmogenic Cardiomyopathy pathogenesis
|
|
Closed | 2016 |
FON_NAZ - Bandi Altre Fondazioni |
Connecting craniofacial malformations with neural crest splicing defects by defining the role of nuclear cyclophilin NKTR (GMR22T1054)
|
|
Ongoing | 2023 |
Horizon Europe - Marie Skłodowska-Curie actions - Staff Exchanges |
Comprehensive and personalized assessment of acute coronary syndrome by multiomic approach and artificial intelligence strategy (CardioSCOPE)
|
|
Ongoing | 2023 |
MIS - Bandi Ministero Salute |
Combined Next-generation sequencing and in vivo approach to uncover the complex genetic basis of GnRH neuron deficiency
|
|
Closed | 2018 |
AL_RIC - Bandi da altri enti di ricerca |
Colchicine for Amyotrophic Lateral Sclerosis: a phase II, randomized, double blind, placebo controlled, multicenter clinical trial (Co-ALS)
|
|
Closed | 2018 |